GLP1S is a GLP-1 receptor agonist studied for its ability to enhance insulin secretion, suppress appetite, and promote weight loss.

Research Focus:

• Type 2 diabetes models
• Weight management research
• Appetite suppression studies
• Cardiovascular health effects

Sources:

STEP-1 obesity trial (NEJM): https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

SELECT cardiovascular outcomes (NEJM): https://www.nejm.org/doi/full/10.1056/NEJMoa2314170

Mechanism & class review (Nature Reviews Endocrinology): https://www.nature.com/articles/s41574-020-00421-8

⚠️ Disclaimer: For research use only. Not intended for human consumption. This information is provided for educational purposes and has not been evaluated by the FDA.